-
ELI LILLY AND COMPANY v. ZYDUS PHARMACEUTICALS USA, INC. DC
- 2:11-cv-02582
- D.N.J.
- Judge: Dennis M. Cavanaugh +1
- Filed: 05/05/2011
- Closed: 03/09/2012
- Latest Docket Entry: 03/09/2012
- PACER
- Docket updated daily
1
Plaintiff
1
Defendant
1
Accused
Product
1
Patent-in-Suit
310
Days in
Litigation
-
ELI LILLY AND COMPANY v. ZYDUS PHARMACEUTICALS USA, INC. DC
- 2:11-cv-02582
- D.N.J.
- Judge: Dennis M. Cavanaugh +1
- Filed: 05/05/2011
- Closed: 03/09/2012
- Latest Docket Entry: 03/09/2012
- PACER
- Docket updated daily
Causes of Action
Other
Willful Patent Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A method of treating attention-deficit/hyperactivity disorder comprising administering to a patient in need of such treatment an effective amount of tomoxetine.
|
Enforceable and Valid
Entry 14 |
2 |
A method of claim 1 wherein the predominantly inattentive type of attention-deficit/hyperactivity disorder is treated.
|
Enforceable and Valid
Entry 14 |
3 |
A method of claim 1 wherein the predominantly hyperactive-impulsive type of attention-deficit/hyperactive disorder is treated.
|
Enforceable and Valid
Entry 14 |
4 |
A method of claim 1 wherein the combined type of attention-deficit/hyperactivity disorder is treated.
|
Enforceable and Valid
Entry 14 |
5 |
A method of claim 1 wherein the patient is an adult.
|
Enforceable and Valid
Entry 14 |
6 |
A method of claim 5 wherein the predominantly inattentive type of attention-deficit/hyperactivity disorder is treated.
|
Enforceable and Valid
Entry 14 |
7 |
A method of claim 5 wherein the predominantly hyperactive-impulsive type of attention-deficit/hyperactive disorder is treated.
|
Enforceable and Valid
Entry 14 |
8 |
A method of claim 5 wherein the combined type of attention-deficit/hyperactivity disorder is treated.
|
Enforceable and Valid
Entry 14 |
9 |
A method of claim 1 wherein the patient is an adolescent.
|
Enforceable and Valid
Entry 14 |
10 |
A method of claim 9 wherein the predominantly inattentive type of attention-deficit/hyperactivity disorder is treated.
|
Enforceable and Valid
Entry 14 |
11 |
A method of claim 9 wherein the predominantly hyperactive-impulsive type of attention-deficit/hyperactive disorder is treated.
|
Enforceable and Valid
Entry 14 |
12 |
A method of claim 9, wherein the combined type of attention-deficit/hyperactivity disorder is treated.
|
Enforceable and Valid
Entry 14 |
13 |
A method of claim 1 wherein the patient is a child.
|
Enforceable and Valid
Entry 14 |
14 |
A method of claim 13 wherein the predominantly inattentive type of attention-deficit/hyperactivity disorder is treated.
|
Enforceable and Valid
Entry 14 |
15 |
A method of claim 13 wherein the predominantly hyperactive-impulsive type of attention-deficit/hyperactive disorder is treated.
|
Enforceable and Valid
Entry 14 |
16 |
A method of claim 13 wherein the combined type of attention-deficit/hyperactivity disorder is treated.
|
Enforceable and Valid
Entry 14 |